4967 — Kobayashi Pharmaceutical Share News
0.000.00%
- ¥541bn
- ¥477bn
- ¥166bn
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 10.1% From 7.54%, Filing Shows
Brief: Nikkei Says Oasis Petitions Kobayashi Pharma To Sue Executives For $67M
Oasis Japan Strategic Fund Has Requested Extraordinary Shareholders' Meeting
Japan's Kirin clinched Fancl takeover to propel health pivot, president says (updated)
Notice Of Withdrawal From Red Yeast Rice Business
Brief: Oasis Management Owns 5.20% Stake In Kobayashi Pharmaceutical - Regulatory Filing
Brief: Kobayashi Pharmaceutical- Chairman And President To Resign Over Beni-Koji Dietary Supplement Problem
Brief: Nikkei Says Kobayashi Pharma Chairman And President To Resign Due To Deadly Supplement
Kobayashi Pharma: investigating 76 deaths, link to supplements
Brief: Kobayashi Pharma Red Yeast Supplements Could Have Been Linked To Additional 76 Deaths - Nikkei Citing Japan Health Minister
Japan companies hog the spotlight as hedge funds tout their top Asia picks
Table: Kobayashi Pharmaceutical -Q1 group results
Newscasts - Second Kobayashi Pharma factory inspected after deaths
Newscasts - Second Kobayashi Pharma factory inspected after deaths
Japanese authorities inspect second Kobayashi Pharma factory after deaths (updated)
A second Kobayashi Pharma Japan factory inspected over deaths
Kobayashi factory searched over deaths possibly linked to supplements (updated)
Kobayashi factory searched over deaths possibly linked to supplements
Brief: Osaka City, Health Ministry Search Factory Of Kobayashi Pharmaceutical Over Health Issues Caused By Dietary Supplement Products - Nikkei